Tris Pharma Kicks Cough Syrup Infringement Claims

Law360, New York (December 21, 2011, 6:53 PM EST) -- A New Jersey federal judge on Wednesday let Tris Pharma Inc. off the hook on allegations that its generic cough suppressant infringes a competitor’s patent, saying Tris had demonstrated that its product was differently formulated, but kept alive claims for an employee's trade secrets theft and unfair competition.

U.S. District Judge Freda L. Wolfson granted Tris’ motion for summary judgment of noninfringement against allegations made by Reckitt Benckiser Inc. and UCB Manufacturing Inc. that Tris’ intentions to market a generic version of Reckitt’s Delsym 7 violated...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.